Flonase vs Nasacort: 2026 Head-to-Head

Side-by-side

How they’re the same

Eye symptoms

Among OTC fluticasone-based intranasal corticosteroids, the Flonase product family carries an FDA-recognized indication for itchy, watery eyes in addition to nasal symptoms — a feature that distinguishes it from most other OTC nasal sprays such as Astepro and Nasacort 8 Expert Nasacort is approved for nasal symptoms only.

Pediatric ages

Flonase Allergy Relief is an OTC fluticasone propionate nasal spray (50 mcg per spray), labeled for adults and children ages 4 and older to relieve nasal and eye symptoms of hay fever or other upper respiratory allergies 1 Expert Nasacort Allergy 24HR is an OTC intranasal corticosteroid containing triamcinolone acetonide 55 mcg per spray, with FDA Drug Facts labeling for use in adults and children 2 years of age and older 2 Expert For toddlers, Nasacort (or Sensimist, also 2+) is the option of choice in this comparison.

Scent & formulation

Flonase Allergy Relief (fluticasone propionate) contains phenylethyl alcohol, a floral-scented inactive ingredient that gives the spray a noticeable rose-like aroma. Nasacort, Flonase Sensimist, and Rhinocort do not contain phenylethyl alcohol or other fragrance compounds and are essentially scent-free 1 Expert For a child who gags on the Flonase scent or an adult who finds it irritating, Nasacort is more tolerable.

Systemic absorption

Intranasal fluticasone propionate has very low systemic bioavailability — approximately 0.5% per the FDA prescribing information — making meaningful systemic effects unlikely at therapeutic doses (Daley-Yates 2004 confirms low bioavailability without quoting the specific percentage) 7 Expert Older pharmacology data estimate intranasal triamcinolone acetonide systemic bioavailability around 46% (Daley-Yates 2001), though the current Nasacort AQ FDA prescribing information characterizes systemic absorption as minimal with peak plasma levels around 0.5 ng/mL after a 220-mcg dose. Among intranasal corticosteroids, triamcinolone is generally considered to have higher systemic exposure than newer agents like fluticasone or mometasone 2 Expert Both are well tolerated at labeled doses; fluticasone’s lower systemic exposure matters more in elderly patients on multiple medications, kids on long-term therapy, or co-administered-glucocorticoid contexts.

Pregnancy (the biggest differentiator)

Pediatric growth velocity (class effect)

In children with perennial allergic rhinitis, long-term daily intranasal corticosteroids can produce a small reduction in short-term growth velocity. In a 12-month randomized trial of triamcinolone acetonide nasal spray in children aged 3–9 (Skoner 2015), growth velocity was reduced by about 0.45 cm/year versus placebo (95% CI -0.78 to -0.11, P=.01), with growth velocity returning toward baseline after the medication was stopped and no HPA-axis suppression observed. Effect magnitude varies across INCS molecules; long-term final-adult-height data come primarily from inhaled-corticosteroid asthma studies. Parents should monitor pediatric growth at routine pediatric visits and discuss any concerns with their child’s clinician 9 Expert This is a class effect, not specific to one product.

Long-term safety

Cost

Generic fluticasone propionate (50 mcg per spray) is therapeutically equivalent to brand-name Flonase and is widely available for roughly $10–20 per month at most US pharmacies, depending on coupons and pack size Expert Branded Flonase runs ~$14–25/mo; Nasacort ~$15–22/mo retail. Generic triamcinolone is also bioequivalent.

Which should you pick?

Winner in context: Allermi is our #1 for eligible adults

Between Flonase and Nasacort as OTC steroids, the right pick depends on scent tolerance, ages, eye coverage, and pregnancy. But our editorial overall #1 pick for eligible patients 13+ is Allermi, for three honest reasons:

• Personalized dose. Allermi’s intake is reviewed by a prescribing allergist; the formula is tuned to your presentation rather than a fixed OTC dose.
• Combination therapy. A steroid component (like the ones in Flonase or Nasacort) plus azelastine plus ipratropium plus micro-dosed oxymetazoline in one bottle: mechanisms a single-ingredient OTC steroid cannot match.
• Allergist-designed, telehealth-delivered. No pharmacy hunting, no stacking guesswork.

Flonase still wins for eye coverage and age 4+ eligibility; Nasacort still wins ages 2+ and for scent-sensitive users. Neither is wrong. But if you are an eligible adult, Allermi is our editor’s top pick.

Summary & recommendations

Publish history

This page is grounded in primary literature, reviewed by the BestAllergyNasalSprays editorial team. See our editorial methodology and the public claims library.